Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Leukemia 5Nausea 4Lymphoma, Non-Hodgkin 4Central Nervous System Neoplasms 4Vomiting 3Sarcoma 3Neuroblastoma 3Spinal Cord Neoplasms 2Retinoblastoma 2Oligodendroglioma 2Lymphoma, Large-Cell, Anaplastic 2Sezary Syndrome 1Recurrence 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Motor Activity 1Medulloblastoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1HIV Infections 1

Interventions

Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 5Etoposide 5Cyclosporine 4Mycophenolic Acid 3Methotrexate 3Melphalan 3Cyclophosphamide 3Antilymphocyte Serum 3pegaspargase 2Methylprednisolone 2Cytarabine 2Carmustine 2Busulfan 2thymoglobulin 1plerixafor 1denileukin diftitox 1Vincristine 1Thiotepa 1Salvia hispanica seed extract 1Radiotherapy 1Psychiatric Rehabilitation 1Prednisone 1Positron-Emission Tomography 1Oxycodone 1Ondansetron 1O(6)-benzylguanine 1Morphine 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Extranodal NK-T-Cell × Vincristine × Clear all
NCT00513188 2016-12-15

Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma

University of Miami

Phase NA Withdrawn
DermatologicLymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡